Follow
Remco J. Molenaar
Remco J. Molenaar
MD/PhD candidate, Academic Medical Center, University of Amsterdam
Verified email at amc.uva.nl
Title
Cited by
Cited by
Year
Recent advances in the molecular understanding of glioblastoma
FE Bleeker, RJ Molenaar, S Leenstra
Journal of neuro-oncology 108, 11-27, 2012
5562012
Wild-type and mutated IDH1/2 enzymes and therapy responses
RJ Molenaar, JP Maciejewski, JW Wilmink, CJF van Noorden
Oncogene 37 (15), 1949-1960, 2018
2532018
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
RJ Molenaar, D Verbaan, S Lamba, C Zanon, JWM Jeuken, ...
Neuro-oncology 16 (9), 1263-1273, 2014
2382014
The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
RJ Molenaar, T Radivoyevitch, JP Maciejewski, CJF van Noorden, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 326-341, 2014
2222014
Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
RJ Molenaar, D Botman, MA Smits, VV Hira, SA van Lith, J Stap, ...
Cancer research 75 (22), 4790-4802, 2015
1532015
Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer
RJ Molenaar, S Sidana, T Radivoyevitch, AS Advani, AT Gerds, ...
Journal of Clinic al Oncology 76, 410, 2017
1342017
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms
RJ Molenaar, S Thota, Y Nagata, B Patel, M Clemente, B Przychodzen, ...
Leukemia 29 (11), 2134-2142, 2015
992015
IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
RJ Molenaar, T Radivoyevitch, Y Nagata, M Khurshed, B Przychodzen, ...
Clinical cancer research 24 (7), 1705-1715, 2018
972018
CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K
VVV Hira, KJ Ploegmakers, F Grevers, U Verbovšek, C Silvestre-Roig, ...
Journal of Histochemistry & Cytochemistry 63 (7), 481-493, 2015
952015
Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation
T Radivoyevitch, RK Sachs, RP Gale, RJ Molenaar, DJ Brenner, BT Hill, ...
Leukemia 30 (2), 285-294, 2016
912016
Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours
RJ Molenaar, RJS Coelen, M Khurshed, E Roos, MWA Caan, ...
BMJ open 7 (6), e014961, 2017
832017
Mutational profiling of kinases in glioblastoma
BA Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJ, Troost D, van ...
BMC Cancer 14, 718, 2014
77*2014
Ion channels in glioblastoma
RJ Molenaar
International Scholarly Research Notices 2011, 2011
762011
In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
M Khurshed, RJ Molenaar, K Lenting, WP Leenders, CJF van Noorden
Oncotarget 8 (30), 49165, 2017
722017
The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma
DA Aderetti, VVV Hira, RJ Molenaar, CJF van Noorden
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (2), 346-354, 2018
692018
Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?
SAM van Lith, AC Navis, K Verrijp, SP Niclou, R Bjerkvig, P Wesseling, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 66-74, 2014
592014
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
T Radivoyevitch, RM Dean, BE Shaw, R Brazauskas, HR Tecca, ...
Leukemia research 74, 130-136, 2018
582018
Phase II Feasibility and biomarker study of neoadjuvant trastuzumab and pertuzumab with chemoradiotherapy for resectable human epidermal growth factor receptor 2–positive …
CI Stroes, S Schokker, A Creemers, RJ Molenaar, MCCM Hulshof, ...
Journal of Clinical Oncology 38 (5), 462, 2020
552020
Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches
VVV Hira, CJF Van Noorden, HE Carraway, JP Maciejewski, RJ Molenaar
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (1), 183-198, 2017
542017
Comparison of different methodologies and cryostat versus paraffin sections for chromogenic immunohistochemistry
VVV Hira, AL de Jong, K Ferro, M Khurshed, RJ Molenaar, ...
Acta histochemica 121 (2), 125-134, 2019
492019
The system can't perform the operation now. Try again later.
Articles 1–20